Kala Bio (KALA) Other Non-Current Liabilities (2016 - 2025)

Kala Bio has reported Other Non-Current Liabilities for 7 years, with the latest figure at $3.2 million in Q2 2025.

• Quarterly Other Non-Current Liabilities fell 23.8% year-over-year to $3.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $3.2 million (down 23.8% YoY) and the FY2024 annual result came in at $4.7 million, up 13.36% from the prior year.
• Other Non-Current Liabilities advanced to $3.2 million in Q2 2025 per KALA's latest filing, from $3.1 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $5.6 million in Q2 2023 and troughed at $3.1 million in Q1 2025.
• A 5-year average of $4.2 million and a median of $4.2 million in 2022 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities jumped 45.56% in 2023, then fell 26.99% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $4.8 million in 2021, then dropped by 12.75% to $4.2 million in 2022, then declined by 2.7% to $4.1 million in 2023, then grew by 13.36% to $4.7 million in 2024, then slumped by 30.67% to $3.2 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.2 million, $3.1 million, and $4.7 million for Q2 2025, Q1 2025, and Q4 2024 respectively.